Home・Aandelen Lijst・Embecta Corp

Embecta Corp

Gesloten

SectorGezondheidszorg

4.42 26.65

Buy Sell

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

3.51

Max

4.68

Belangrijke statistieken
By Trading Economics
Inkomsten	-48M -4.1M
Verkoop	-39M 222M
K/W Sectorgemiddelde	1.928 68.51
EPS	0.27
Dividendrendement	16.48
Winstmarge	-1.849
Werknemers	1,850
EBITDA	-51M 45M

Aanbevelingen
By TipRanks
Aanbevelingen	Sell
12 Maanden Prognose	-14.29% downside

Dividenden
By Acuity
Dividendrendement Sectorgemiddelde	16.48% 2.29%
Volgende Winsten	7 aug 2026
Volgende dividenddatum	15 sep 2026
Volgende Ex Dividend datum	27 aug 2026

Marktinformatie
By TradingEconomics
Marktkapitalisatie	-327M 221M
Vorige openingsprijs	-22.23
Vorige sluitingsprijs	4.42

Nieuwssentiment

By Acuity

72%

28%

308 / 340 Rangschikking in Healthcare

Embecta Corp Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

6 aug 2026, 23:42 UTC

Embecta Corp shares are higher in after-market hours, recovering from earlier lows. No specific news was identified to explain this movement.

5 aug 2026, 22:36 UTC

News

Embecta Corp faces a securities fraud class action lawsuit over misleading fiscal statements, contributing to a modest decline in after-market trading.

4 aug 2026, 19:26 UTC

Embecta Corp shares are higher during Tuesday's session, reaching a session high. No specific company news was identified to explain the upward movement.

3 aug 2026, 20:03 UTC

Embecta Corp shares are higher today, benefiting from positive investor sentiment in the health care supplies sector amid a rising broader market.

31 jul 2026, 21:02 UTC

Embecta Corp shares are lower in after-market hours, continuing a recent decline amid broader market concerns over inflation and rising interest rates.

30 jul 2026, 21:02 UTC

Embecta Corp shares are higher in after-market trading, amid positive market sentiment focused on corporate earnings despite geopolitical tensions and inflation concerns.

29 jul 2026, 19:04 UTC

Embecta Corp gains amid a strong Health Care Supplies sub-sector, despite pulling back from earlier session highs. Overall, shares are higher since Tuesday's close.

28 jul 2026, 22:01 UTC

Embecta Corp shares are higher in after-market hours, continuing a positive trend since Tuesday's close. No specific news was identified to explain the movement.

27 jul 2026, 18:03 UTC

Embecta Corp shares are trading higher, continuing a rise since Friday amid broader market movements and easing inflation concerns, despite earlier pulling back from session highs.

24 jul 2026, 21:31 UTC

News

Embecta Corp is facing a securities class action lawsuit for allegedly misleading investors about its fiscal results, contributing to lower after-market hours trading.

22 jul 2026, 18:02 UTC

News

Embecta Corp shares are lower today amid a securities fraud class action lawsuit filed by Levi & Korsinsky, LLP, targeting misrepresentation of financial health.

21 jul 2026, 23:01 UTC

Embecta Corp shares are higher in after-market trading, reflecting a strong position above its 20-day moving average and near the upper end of its one-month range.

20 jul 2026, 19:52 UTC

Embecta Corp shares are rising sharply, reaching the upper end of their one-month range amid positive broader market sentiment, particularly from Asian markets.

Peer Vergelijking

Prijswijziging

Embecta Corp Prognose

Koersdoel

By TipRanks

-14.29% neerwaarts potentieel

12 Maanden Prognose

Gemiddelde 3 USD -14.29%

Hoogste 3 USD

Laagste 3 USD

Gebaseerd op 2 Wall Street-analisten die 12-maands prijsdoelen bieden voor Embecta Corp - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Sell

2 ratings

Buy

Hold

Sell

Gebaseerd op 2 analisten die aandelenratings hebben gegeven aan Embecta Corp - Dist in de afgelopen 3 maanden.

Sentiment

By Acuity

308 / 340 Rangschikking in Gezondheidszorg

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

Over Embecta Corp

Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety injection devices, as well as digital applications to assist people with managing patient's diabetes. The company primarily sells its products to wholesalers and distributors in the United States and internationally. Embecta Corp. was founded in 1924 and is headquartered in Parsippany, New Jersey.